Hudson Alexandra, Finlayson Laura
Dalhousie Medicine, Halifax, Nova Scotia, Canada
Dalhousie Medicine, Halifax, Nova Scotia, Canada.
J Cutan Med Surg. 2016 Nov;20(6):596-599. doi: 10.1177/1203475416661312. Epub 2016 Jul 19.
Diffuse cutaneous bullous mastocytosis is the most rare subtype of cutaneous mastocytosis, characterized by generalized skin infiltration with mast cells and blistering.
To increase the awareness of the natural history and potential adverse complications of this rare cutaneous condition.
We report a case of a male diagnosed on day 7 of life with follow-up of his progression over 6 years. When he was 2.5 months old, he was admitted to hospital postvaccinations with a flare of his blistering that was complicated by disseminated intravascular coagulation and polyuric acute tubular necrosis. Blistering ceased at 3 years, but at 6 years, extensive urtication continued in response to known triggers and a suboptimal dose of mast cell membrane stabilizers and histamine-1 and -2 receptor antagonists.
This case discusses the progression of this rare condition over 6 years and highlights the importance of reaching optimal pharmacologic blockage of histamine-1 and -2 receptors and stabilization of mast cell membranes in patients persistently experiencing ongoing pruritus, urtication, and flushing symptoms.
弥漫性皮肤大疱性肥大细胞增多症是皮肤肥大细胞增多症最罕见的亚型,其特征为肥大细胞广泛浸润皮肤并出现水疱。
提高对这种罕见皮肤病自然病程及潜在不良并发症的认识。
我们报告一例男性病例,该病例在出生后第7天确诊,并对其6年病程进行了随访。他2.5个月大时,接种疫苗后因水疱发作入院,并发弥散性血管内凝血和多尿性急性肾小管坏死。水疱在3岁时停止发作,但6岁时,对已知触发因素以及剂量不足的肥大细胞膜稳定剂和组胺-1及-2受体拮抗剂仍会出现广泛的风团。
本病例讨论了这种罕见疾病6年的病程,并强调了对于持续出现瘙痒、风团和潮红症状的患者,实现组胺-1和-2受体的最佳药物阻断以及肥大细胞膜稳定的重要性。